Nisa Investment Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-717
| Closed | -$29.3K | – | 3086 |
|
|
2024
Q2 | $29.3K | Buy |
717
+60
| +9% | +$2.45K | ﹤0.01% | 1815 |
|
|
2024
Q1 | $27.8K | Buy |
657
+57
| +10% | +$2.41K | ﹤0.01% | 1793 |
|
|
2023
Q4 | $25.4K | Buy |
600
+20
| +3% | +$848 | ﹤0.01% | 1811 |
|
|
2023
Q3 | $12.7K | Sell |
580
-1,120
| -66% | -$24.4K | ﹤0.01% | 2127 |
|
|
2023
Q2 | $54K | Buy |
1,700
+280
| +20% | +$8.9K | ﹤0.01% | 1729 |
|
|
2023
Q1 | $35K | Hold |
1,420
| – | – | ﹤0.01% | 1821 |
|
|
2022
Q4 | $45K | Hold |
1,420
| – | – | ﹤0.01% | 1816 |
|
|
2022
Q3 | $40K | Buy |
1,420
+40
| +3% | +$1.13K | ﹤0.01% | 1833 |
|
|
2022
Q2 | $36K | Buy |
1,380
+440
| +47% | +$11.5K | ﹤0.01% | 1857 |
|
|
2022
Q1 | $33K | Sell |
940
-1,256
| -57% | -$44.1K | ﹤0.01% | 1947 |
|
|
2021
Q4 | $57K | Buy |
+2,196
| New | +$57K | ﹤0.01% | 1699 |
|